Clinical Trial Update: Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating fecal microbiota transplantation for steroid-resistant or dependent acute gastrointestinal graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic and Lymphoid Cell Neoplasm

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | Status: COMPLETED